Clincosm LogoSign in Get a demo

acute myeloid leukemia

Showing NaN - NaN of 117
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Collecting and Storing Tissue From Young Patients With Cancer

Recruiting
  • Acute Lymphoblastic Leukemia
  • +13 more
  • Cytology Specimen Collection Procedure
  • Laboratory Biomarker Analysis
  • Birmingham, Alabama
  • +68 more
Aug 4, 2022

Acute Myeloid Leukemia, Adult Acute Megakaryoblastic Leukemia, Adult Acute Monoblastic Leukemia Trial in United States

Completed
Has Results
  • Acute Myeloid Leukemia
  • +19 more
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +8 more
  • Lewes, Delaware
  • +16 more
Aug 3, 2022

Acute Myeloid Leukemia Trial in Canada, Spain, United States (Decitabine and Cedazuridine (ASTX727), Venetoclax)

Recruiting
  • Acute Myeloid Leukemia
  • Los Angeles, California
  • +15 more
Jul 29, 2022

Acute Myeloid Leukemia, MDS, Chronic Myelomonocytic Leukemia Trial in Canada, United States (CFI-400945, Azacitidine,

Recruiting
  • Acute Myeloid Leukemia
  • +5 more
  • Duarte, California
  • +7 more
Jul 20, 2022

Chimerism and Relapse Post Bone Marrow/Hematopoietic Cell

Recruiting
  • Acute Myeloid Leukemia
  • +2 more
    • Brisbane, California
    • +4 more
    Jul 18, 2022

    Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Mixed Phenotype Acute Leukemia Trial in Atlanta, New York (MRX-2843)

    Recruiting
    • Acute Myeloid Leukemia
    • +2 more
    • Atlanta, Georgia
    • +2 more
    Jul 6, 2022

    Acute Myeloid Leukemia Trial in United States (Dociparastat sodium, Placebo)

    Active, not recruiting
    • Acute Myeloid Leukemia
    • Dociparastat sodium
    • Placebo
    • Orange, California
    • +13 more
    Jun 15, 2022

    Acute Myeloid Leukemia, AML, Adult, Multiple Myeloma Trial in United States (FT538, Cyclophosphamide, Fludarabine)

    Recruiting
    • Acute Myeloid Leukemia
    • +3 more
    • Denver, Colorado
    • +8 more
    May 19, 2022

    Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndrome Trial in Worldwide (biological, drug, procedure)

    Terminated
    Has Results
    • Acute Myeloid Leukemia
    • +2 more
    • ATIR101
    • +3 more
    • Duarte, California
    • +41 more
    Apr 28, 2022

    Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in France, United States (SY-1425 (tamibarotene), azacitidine,

    Active, not recruiting
    • Acute Myeloid Leukemia
    • Myelodysplastic Syndrome
    • SY-1425 (tamibarotene)
    • +2 more
    • Hartford, Connecticut
    • +25 more
    May 4, 2022

    Acute Myeloid Leukemia Trial in Canada, Puerto Rico, United States (procedure, drug, behavioral)

    Recruiting
    • Acute Myeloid Leukemia
    • Allogeneic Hematopoietic Stem Cell Transplantation
    • +13 more
    • Birmingham, Alabama
    • +187 more
    Apr 28, 2022

    Advanced Solid Tumor, Non Hodgkin Lymphoma, Acute Myeloid Leukemia Trial in United States (BTX-1188)

    Recruiting
    • Advanced Solid Tumor
    • +2 more
    • Duarte, California
    • +3 more
    Apr 18, 2022

    Acute Myeloid Leukemia Trial in Worldwide (Alvocidib, Cytarabine, Mitoxantrone)

    Terminated
    Has Results
    • Acute Myeloid Leukemia
    • Scottsdale, Arizona
    • +37 more
    Apr 4, 2022

    Acute Myeloid Leukemia Trial in United States (Tamibarotene, Venetoclax, Azacitidine)

    Recruiting
    • Acute Myeloid Leukemia
    • Duarte, California
    • +7 more
    Mar 27, 2022

    Acute Myeloid Leukemia Trial in Worldwide (Uproleselan, Placebo)

    Active, not recruiting
    • Acute Myeloid Leukemia
    • La Jolla, California
    • +69 more
    Apr 5, 2022

    Acute Myeloid Leukemia Trial in Baltimore, New York, Chapel Hill (Alvocidib, Cytarabine, Daunorubicin)

    Completed
    Has Results
    • Acute Myeloid Leukemia
    • Baltimore, Maryland
    • +2 more
    Apr 4, 2022

    Acute Myeloid Leukemia, MDS Trial in United States (CG-806)

    Recruiting
    • Acute Myeloid Leukemia
    • Myelodysplastic Syndromes
    • Duarte, California
    • +9 more
    Mar 4, 2022

    Acute Myeloid Leukemia, Relapsed Adult AML Trial in United States (Lintuzumab-Ac225, Venetoclax, Spironolactone)

    Recruiting
    • Acute Myeloid Leukemia
    • Relapsed Adult AML
    • Lintuzumab-Ac225
    • +2 more
    • Los Angeles, California
    • +4 more
    Feb 22, 2022

    Acute Myeloid Leukemia, Acute Myelogenous Leukemia, Myelodysplastic Syndrome Trial in Worldwide (FT-2102 (olutasidenib),

    Active, not recruiting
    • Acute Myeloid Leukemia
    • +2 more
    • FT-2102 (olutasidenib)
    • +2 more
    • Los Angeles, California
    • +59 more
    Mar 2, 2022

    Acute Myeloid Leukemia, Leukemia, Acute Myeloid, Myeloid Leukemia, Acute Trial in Canada, United States (Iomab-B, Conventional

    Active, not recruiting
    • Acute Myeloid Leukemia
    • +8 more
    • Gilbert, Arizona
    • +23 more
    Feb 22, 2022

    Acute Myeloid Leukemia Trial in United States (Atezolizumab, Hu5F9-G4)

    Terminated
    Has Results
    • Acute Myeloid Leukemia
    • Sacramento, California
    • +3 more
    Dec 3, 2021

    Acute Myeloid Leukemia Trial in United States (ASTX660, ASTX727)

    Active, not recruiting
    • Acute Myeloid Leukemia
    • San Francisco, California
    • +14 more
    Jan 24, 2022

    Myelodysplastic Syndrome, Acute Myeloid Leukemia, Myeloproliferative Tumor Trial in United States (APR-246, Azacitidine)

    Completed
    Has Results
    • Myelodysplastic Syndrome
    • +3 more
    • Tampa, Florida
    • +5 more
    Jan 14, 2022

    Acute Myeloid Leukemia Trial in New York (CPX-351, Gemtuzumab Ozogamicin)

    Recruiting
    • Acute Myeloid Leukemia
    • New York, New York
      Weill Cornell Medical College
    Dec 21, 2021

    Oncology, Acute Myeloid Leukemia Trial in United States (Open Label LAM-003)

    Completed
    • Oncology
    • Acute Myeloid Leukemia
    • Open Label LAM-003
    • New Haven, Connecticut
    • +5 more
    Dec 17, 2021